US › Healthcare

MDxHealth SA (MDXH)

US · Healthcare · Diagnostics & Research

$0.21-65.73%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$27.2M

Revenue YoY

+2.3%

Net profit

$-11.5M

EPS

$-0.18

EPS estimate

$-0.12

Net margin

-42.4%

EPS came in at -0.18 against a street estimate of -0.12 — a miss of 50.0%.

Key statistics

Market cap

$63.0M

Forward P/E

27.7

P/B

23.64

Book value

$-0.59

EPS (TTM)

$-0.70

52-week high

$5.33

52-week low

$0.40

50-day MA

$0.63

200-day MA

$1.73

Beta

-518,287.38

Analyst view

Analysts rate MDxHealth SA a buy (4 buy, 2 hold, 0 sell out of 6) with an average price target of $1.80.

Shareholding

Insiders

22.14%

Institutions

45.15%

Largest institutional holders

Fund	Stake
Rhumbline Advisers	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for MDxHealth SA — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.